Analysts’ Updated EPS Estimates for June 17th (ACHR, ARGX, AVTE, BLDR, CNK, CRSP, GPCR, JOBY, LEGN, LLY)

Analysts’ updated eps estimates for Monday, June 17th:

Archer Aviation (NYSE:ACHR) had its overweight rating reiterated by analysts at Cantor Fitzgerald. Cantor Fitzgerald currently has a $10.00 target price on the stock.

argenx (NASDAQ:ARGX) had its overweight rating reissued by analysts at Piper Sandler. The firm currently has a $522.00 target price on the stock.

Aerovate Therapeutics (NASDAQ:AVTE) had its hold rating reissued by analysts at Jefferies Financial Group Inc.. The firm currently has a $2.00 target price on the stock, down from their previous target price of $65.00.

Builders FirstSource (NYSE:BLDR) had its hold rating reaffirmed by analysts at Zelman & Associates.

Cinemark (NYSE:CNK) had its outperform rating reissued by analysts at Barrington Research. The firm currently has a $24.00 target price on the stock.

CRISPR Therapeutics (NASDAQ:CRSP) had its overweight rating reissued by analysts at Piper Sandler. They currently have a $105.00 price target on the stock.

Structure Therapeutics (NASDAQ:GPCR) had its overweight rating reiterated by analysts at Cantor Fitzgerald. The firm currently has a $65.00 price target on the stock.

Joby Aviation (NYSE:JOBY) had its overweight rating reissued by analysts at Cantor Fitzgerald. They currently have a $10.00 target price on the stock.

Legend Biotech (NASDAQ:LEGN) had its overweight rating reaffirmed by analysts at Piper Sandler. Piper Sandler currently has a $90.00 target price on the stock.

Eli Lilly and Company (NYSE:LLY) had its overweight rating reiterated by analysts at Cantor Fitzgerald. They currently have a $885.00 price target on the stock.

Intuitive Machines (NASDAQ:LUNR) had its overweight rating reaffirmed by analysts at Cantor Fitzgerald. They currently have a $10.00 target price on the stock.

Novo Nordisk A/S (NYSE:NVO) had its overweight rating reiterated by analysts at Cantor Fitzgerald. Cantor Fitzgerald currently has a $160.00 target price on the stock.

Ouster (NYSE:OUST) had its neutral rating reiterated by analysts at Cantor Fitzgerald. The firm currently has a $13.00 target price on the stock.

Pfizer (NYSE:PFE) had its overweight rating reiterated by analysts at Cantor Fitzgerald. The firm currently has a $45.00 target price on the stock.

Rivian Automotive (NASDAQ:RIVN) had its overweight rating reiterated by analysts at Cantor Fitzgerald. The firm currently has a $15.00 target price on the stock.

Skye Bioscience (NASDAQ:SKYE) had its overweight rating reissued by analysts at Cantor Fitzgerald. The firm currently has a $14.00 price target on the stock.

Skye Bioscience (NASDAQ:SKYE) had its overweight rating reissued by analysts at Cantor Fitzgerald. The firm currently has a $14.00 target price on the stock.

Interface (NASDAQ:TILE) had its outperform rating reissued by analysts at Barrington Research. They currently have a $22.00 target price on the stock.